AABB represents the interests of AABB members, donors and patients who are in need of life-saving blood and biotherapies products by monitoring emerging issues; engaging the Food and Drug Administration and the Centers for Disease Control and Prevention regarding new information and data; and by providing formal comments to government agencies during the development of regulations and recommendations. AABB monitors the landscape of federal regulatory activities to assist members with implementation and compliance strategies for new regulations and recommendations.
KAREN PALMER, MT(ASCP) CQA(ASQ)
Director, Regulatory Affairs
kpalmer@aabb.org
301.215.6514
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977